nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call to arms: Using RNAi screening to improve oncolytic viral therapy
|
Mahoney, D.J. |
|
2010 |
71-72 |
2-3 |
p. 161-167 7 p. |
artikel |
2 |
Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
|
Harrington, K.J. |
|
2010 |
71-72 |
2-3 |
p. 91-98 8 p. |
artikel |
3 |
Combining oncolytic virotherapy and tumour vaccination
|
Bridle, Byram W. |
|
2010 |
71-72 |
2-3 |
p. 143-148 6 p. |
artikel |
4 |
Conference Calendar
|
|
|
2001 |
71-72 |
2-3 |
p. 287- 1 p. |
artikel |
5 |
Conference calendar
|
|
|
2004 |
71-72 |
2-3 |
p. VII-VIII nvt p. |
artikel |
6 |
Control of interferon signaling in human papillomavirus infection
|
Koromilas*, Antonis E. |
|
2001 |
71-72 |
2-3 |
p. 157-170 14 p. |
artikel |
7 |
Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14
|
Wisniewski, Hans-Georg |
|
2004 |
71-72 |
2-3 |
p. 129-146 18 p. |
artikel |
8 |
Cytokine signaling and Epstein-Barr virus-mediated cell transformation
|
Mosialos, George |
|
2001 |
71-72 |
2-3 |
p. 259-270 12 p. |
artikel |
9 |
Cytokines in Mycoplasma pneumoniae infections
|
Yang, Jun |
|
2004 |
71-72 |
2-3 |
p. 157-168 12 p. |
artikel |
10 |
Directing systemic oncolytic viral delivery to tumors via carrier cells
|
Nakashima, Hiroshi |
|
2010 |
71-72 |
2-3 |
p. 119-126 8 p. |
artikel |
11 |
Double trouble for tumours: Exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses
|
De Silva, Naomi |
|
2010 |
71-72 |
2-3 |
p. 135-141 7 p. |
artikel |
12 |
Editorial Board
|
|
|
2010 |
71-72 |
2-3 |
p. CO2- 1 p. |
artikel |
13 |
Editorial Board
|
|
|
2004 |
71-72 |
2-3 |
p. IFC- 1 p. |
artikel |
14 |
Facts and Faces
|
|
|
2001 |
71-72 |
2-3 |
p. 283-286 4 p. |
artikel |
15 |
Foreword
|
Bell, John |
|
2010 |
71-72 |
2-3 |
p. 83-84 2 p. |
artikel |
16 |
Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB
|
Jeang, Kuan-Teh |
|
2001 |
71-72 |
2-3 |
p. 207-217 11 p. |
artikel |
17 |
GM-CSF-armed, replication-competent viruses for cancer
|
Burke, James M. |
|
2010 |
71-72 |
2-3 |
p. 149-151 3 p. |
artikel |
18 |
Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors
|
Stantchev, Tzanko S. |
|
2001 |
71-72 |
2-3 |
p. 219-243 25 p. |
artikel |
19 |
Hunting for genes by functional screens
|
Kiss-Toth, Endre |
|
2004 |
71-72 |
2-3 |
p. 97-102 6 p. |
artikel |
20 |
Impact of tumor microenvironment on oncolytic viral therapy
|
Wojton, Jeffrey |
|
2010 |
71-72 |
2-3 |
p. 127-134 8 p. |
artikel |
21 |
Introduction—Cytokine receptors, signaling pathways and viruses
|
Hiscott, J. |
|
2001 |
71-72 |
2-3 |
p. 129-131 3 p. |
artikel |
22 |
Lipid rafts in cytokine signaling
|
Rao, Rakesh |
|
2004 |
71-72 |
2-3 |
p. 103-110 8 p. |
artikel |
23 |
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
|
Wielockx, Ben |
|
2004 |
71-72 |
2-3 |
p. 111-115 5 p. |
artikel |
24 |
Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression
|
Julkunen, Ilkka |
|
2001 |
71-72 |
2-3 |
p. 171-180 10 p. |
artikel |
25 |
Molecular piracy of Kaposi's sarcoma associated herpesvirus
|
Choi, Joong-Kook |
|
2001 |
71-72 |
2-3 |
p. 245-257 13 p. |
artikel |
26 |
Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval
|
Breitbach, Caroline J. |
|
2010 |
71-72 |
2-3 |
p. 85-89 5 p. |
artikel |
27 |
Novel oncolytic viruses: Riding high on the next wave?
|
Stanford, Marianne M. |
|
2010 |
71-72 |
2-3 |
p. 177-183 7 p. |
artikel |
28 |
Oncolytic parvoviruses as cancer therapeutics
|
Rommelaere, Jean |
|
2010 |
71-72 |
2-3 |
p. 185-195 11 p. |
artikel |
29 |
Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus
|
Rahman, Masmudur M. |
|
2010 |
71-72 |
2-3 |
p. 169-175 7 p. |
artikel |
30 |
Oncolytic viruses and cancer therapy
|
Norman, Kara L. |
|
2001 |
71-72 |
2-3 |
p. 271-282 12 p. |
artikel |
31 |
Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells
|
Nguyen, Thi Lien-Anh |
|
2010 |
71-72 |
2-3 |
p. 153-159 7 p. |
artikel |
32 |
Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil
|
Zemp, Franz J. |
|
2010 |
71-72 |
2-3 |
p. 103-117 15 p. |
artikel |
33 |
Overlapping motifs in the membrane-proximal region of cytokine receptor accessory and signaling subunits
|
D’Andrea, Richard J. |
|
2004 |
71-72 |
2-3 |
p. 83-85 3 p. |
artikel |
34 |
Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme
|
Goetz, Christian |
|
2010 |
71-72 |
2-3 |
p. 197-203 7 p. |
artikel |
35 |
Silencing STATs: lessons from paramyxovirus interferon evasion
|
Horvath, Curt M. |
|
2004 |
71-72 |
2-3 |
p. 117-127 11 p. |
artikel |
36 |
The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression
|
Kalvakolanu, Dhananjaya V. |
|
2004 |
71-72 |
2-3 |
p. 169-194 26 p. |
artikel |
37 |
The interferon system and interferon regulatory factor transcription factors – studies from gene knockout mice
|
Sato, Mitsuharu |
|
2001 |
71-72 |
2-3 |
p. 133-142 10 p. |
artikel |
38 |
The role of epidermal growth factor and its receptors in mammalian CNS
|
Wong, Richard Wing Chuen |
|
2004 |
71-72 |
2-3 |
p. 147-156 10 p. |
artikel |
39 |
The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
|
Levy, David E. |
|
2001 |
71-72 |
2-3 |
p. 143-156 14 p. |
artikel |
40 |
T1/ST2—an IL-1 receptor-like modulator of immune responses
|
Trajkovic, Vladimir |
|
2004 |
71-72 |
2-3 |
p. 87-95 9 p. |
artikel |
41 |
United virus: The oncolytic tag-team against cancer!
|
Le Bœuf, Fabrice |
|
2010 |
71-72 |
2-3 |
p. 205-211 7 p. |
artikel |
42 |
Viral proteins and the mitochondrial apoptotic checkpoint
|
Everett, Helen |
|
2001 |
71-72 |
2-3 |
p. 181-188 8 p. |
artikel |
43 |
Virus therapy for bladder cancer
|
Burke, James |
|
2010 |
71-72 |
2-3 |
p. 99-102 4 p. |
artikel |
44 |
X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis
|
Diao, Jingyu |
|
2001 |
71-72 |
2-3 |
p. 189-205 17 p. |
artikel |